-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Regulus Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from Q3 2012 to Q1 2025.
- Regulus Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Mar 2025 was 66.2M shares, a 130% increase year-over-year.
- Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 56.3M shares, a 197% increase from 2023.
- Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 19M shares, a 24.2% increase from 2022.
- Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 15.3M shares, a 78.1% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)